Both AKI Stage 1A and 1B Increase Mortality in Cirrhosis, suggests study
Written By : Dr Riya Dave
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-08-31 15:15 GMT | Update On 2025-09-01 05:35 GMT
Advertisement
Researchers have determined in a new study that even mild acute kidney injury (AKI) in cirrhosis stage 1A, greatly elevates mortality risk over no AKI in patients. The research further identified that stage 1B is an even greater risk, almost five times higher than no AKI. This study was published in the Journal of Clinical and Experimental Hepatology by Yue-Meng and colleagues.
AKI is a frequent complication in cirrhotic patients, but the division of AKI stage 1 into 1A and 1B has been controversial, with various studies showing conflicting results. The present systematic review and meta-analysis presents the strongest evidence up to now, which indicates the need for early detection and treatment of both subtypes.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.